Vitamin D's hidden power: immune cell changes revealed in healthy volunteers
NCT ID NCT05654818
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how high doses of vitamin D change immune cells in 56 healthy adults over 3 months. Researchers used advanced lab tests to measure different types of immune cells before and after treatment. The goal was to better understand vitamin D's effects on the immune system, which may help explain its potential role in diseases like multiple sclerosis (MS).
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
56 people
The number who actually took part.
- Started
-
Apr 2023
- Finished
-
Oct 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * Women of childbearing potential must have effective contraception during the study period. Effective contraception is defined by a low failure rate (less than 1% per year) when used correctly and consistently, such as implants, injectables, oral contraceptives, IUDs, abstinence, or partner vasectomy. A urine pregnancy test will be performed at inclusion. Exclusion Criteria: * The subject is participating in another therapeutic study, or is in a period of exclusion determined by a previous study * The subject is unable to express their consent * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship * Pregnant or breastfeeding * Infectious disease or vaccination within previous 3 months * Chronic psychiatric disease, or disease that, in the opinion of the investigator ,may put the patient at risk or affect compliance. * Chronic inflammatory or dysimmune disease or subject on immunomodulatory or immunosuppressive therapy (including corticosteroids) within the last 3 months. * Uncontrolled epilepsy. * Known vitamin D deficiency secondary to active or other digestive disease (celiac disease, IBD, gastrectomy or bypass, cirrhosis, short bowel syndrome, nephrotic syndrome, hyperthyroidism, hypoparathyroidism, cancer, granulomatous pathology, lymphoma, rickettsiosis). * History of hypercalcemia, osteopenia or osteoporosis, urinary lithiasis, heart rhythm disorders. * Pathology requiring a daily intake of more than 1 gram of Calcium. * Contraindication to vitamin D3 treatment as mentioned on the VIDAL documentation of UVEDOSE. * Treatment affecting vitamin D metabolism other than corticosteroids: anti-epileptic drugs \[phenobarbital, primidone, phenytoin\], rifampicin, isoniazid, ketoconazole, 5-FU and leucovorin, thiazide diuretic. * Active vitamin supplementation or dietary supplements rich in vitamin D. * Present or past neurological symptoms that may suggest an undiagnosed inflammatory neurological pathology.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Vitamin D deficiency are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nîmes
Nîmes, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could vitamin d play a role in sleep apnea severity?
- One vitamin a pill before transplant: a new shield against a deadly complication?
- Could your bone health decide if a dental implant lasts?
- Could vitamin d levels influence asthma control?
- Could vitamin d levels influence cholesterol in obese diabetes patients?
- Vitamin d deficiency may undermine dental implants — trial tests if supplements can fix it